These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 11481351

  • 21. High dose cyclophosphamide with carboplatin: a tolerable regimen suitable for dose intensification in children with solid tumors.
    Kreissman SG, Rackoff W, Lee M, Breitfeld PP.
    J Pediatr Hematol Oncol; 1997; 19(4):309-12. PubMed ID: 9256829
    [Abstract] [Full Text] [Related]

  • 22. Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942.
    Wells RJ, Reid JM, Ames MM, Mares WL, Krailo MD, Seibel NL, Mosher R, Reaman GH, Wiersma SR.
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):89-93. PubMed ID: 11990712
    [Abstract] [Full Text] [Related]

  • 23. Fractionated cyclophosphamide and etoposide for children with advanced or refractory solid tumors: a phase II window study.
    Mantadakis E, Herrera L, Leavey PJ, Bash RO, Winick NJ, Kamen BA.
    J Clin Oncol; 2000 Jul; 18(13):2576-81. PubMed ID: 10893289
    [Abstract] [Full Text] [Related]

  • 24. Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors.
    Kushner BH, Kramer K, Meyers PA, Wollner N, Cheung NK.
    Med Pediatr Oncol; 2000 Nov; 35(5):468-74. PubMed ID: 11070479
    [Abstract] [Full Text] [Related]

  • 25. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study.
    Bond M, Bernstein ML, Pappo A, Schultz KR, Krailo M, Blaney SM, Adamson PC.
    Pediatr Blood Cancer; 2008 Feb; 50(2):254-8. PubMed ID: 17262795
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B study.
    Lilenbaum RC, Miller AA, Batist G, Bernard S, Hollis DR, Rosner GL, Egorin MJ, Schilsky RL, Ratain MJ.
    J Clin Oncol; 1998 Oct; 16(10):3302-9. PubMed ID: 9779705
    [Abstract] [Full Text] [Related]

  • 29. Response of children with stage IV soft tissue sarcoma to topotecan and carboplatin: a phase II window trial of the cooperative soft tissue sarcoma group.
    Bochennek K, Dantonello T, Koscielniak E, Claviez A, Dirksen U, Sauerbrey A, Beilken A, Klingebiel T.
    Klin Padiatr; 2013 Nov; 225(6):309-14. PubMed ID: 23946091
    [Abstract] [Full Text] [Related]

  • 30. Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors.
    Vo KT, Karski EE, Nasholm NM, Allen S, Hollinger F, Gustafson WC, Long-Boyle JR, Shiboski S, Matthay KK, DuBois SG.
    Oncotarget; 2017 Apr 04; 8(14):23851-23861. PubMed ID: 27793021
    [Abstract] [Full Text] [Related]

  • 31. Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience.
    Büyükkapu Bay S, Kebudi R, Görgün O, Zülfikar B, Darendeliler E, Çakır FB.
    J Oncol Pharm Pract; 2019 Sep 04; 25(6):1343-1348. PubMed ID: 30080131
    [Abstract] [Full Text] [Related]

  • 32. Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes.
    Pentheroudakis G, Briasoulis E, Karavassilis V, Mauri D, Tzamakou E, Rammou D, Pavlidis N.
    Chemotherapy; 2005 May 04; 51(2-3):154-61. PubMed ID: 15886476
    [Abstract] [Full Text] [Related]

  • 33. Combined continuous infusion etoposide with high-dose cyclophosphamide for refractory neuroblastoma: a phase II study from the Société Française d'Oncologie Pédiatrique.
    Méresse V, Vassal G, Michon J, De Cervens C, Courbon B, Rubie H, Perel Y, Landman J, Chastagnier P, De Valck C.
    J Clin Oncol; 1993 Apr 04; 11(4):630-7. PubMed ID: 8478658
    [Abstract] [Full Text] [Related]

  • 34. Topotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma Committee.
    Compostella A, Affinita MC, Casanova M, Milano GM, Scagnellato A, Dall'Igna P, Chiaravalli S, Pierobon M, Manzitti C, Zanetti I, Schiavetti A, Sorbara S, Mura RM, Ruggiero A, Ferrari A, Bisogno G.
    Tumori; 2019 Apr 04; 105(2):138-143. PubMed ID: 30131003
    [Abstract] [Full Text] [Related]

  • 35. Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial.
    Simon T, Längler A, Harnischmacher U, Frühwald MC, Jorch N, Claviez A, Berthold F, Hero B.
    J Cancer Res Clin Oncol; 2007 Sep 04; 133(9):653-61. PubMed ID: 17479288
    [Abstract] [Full Text] [Related]

  • 36. High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors.
    Chan KW, Petropoulos D, Choroszy M, Herzog C, Jaffe N, Ater J, Korbling M.
    Bone Marrow Transplant; 1997 Dec 04; 20(12):1039-43. PubMed ID: 9466276
    [Abstract] [Full Text] [Related]

  • 37. A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
    Cash T, Jonus HC, Tsvetkova M, Beumer JH, Sadanand A, Lee JY, Henry CJ, Aguilera D, Harvey RD, Goldsmith KC.
    Pediatr Blood Cancer; 2023 Aug 04; 70(8):e30405. PubMed ID: 37158620
    [Abstract] [Full Text] [Related]

  • 38. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).
    Children's Oncology Group (CCG 09709)Children's Hospital Los Angeles and the Department Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, USA. jvillablanca@chla.usc.edu, Villablanca JG, Krailo MD, Ames MM, Reid JM, Reaman GH, Reynolds CP.
    J Clin Oncol; 2006 Jul 20; 24(21):3423-30. PubMed ID: 16849757
    [Abstract] [Full Text] [Related]

  • 39. A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma.
    Garaventa A, Luksch R, Biasotti S, Severi G, Pizzitola MR, Viscardi E, Prete A, Mastrangelo S, Podda M, Haupt R, De Bernardi B.
    Cancer; 2003 Dec 01; 98(11):2488-94. PubMed ID: 14635085
    [Abstract] [Full Text] [Related]

  • 40. Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.
    Mascarenhas L, Felgenhauer JL, Bond MC, Villaluna D, Femino JD, Laack NN, Ranganathan S, Meyer J, Womer RB, Gorlick R, Krailo MD, Marina N.
    Pediatr Blood Cancer; 2016 Mar 01; 63(3):493-8. PubMed ID: 26579879
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.